Clinical Study on Xiaotiaozong Decoction(小调宗汤)in Treatment of Patients with Coronary Heart Disease Angina Pectoris
Objective To observe the clinical effect of Xiaotiaozong Decoction(小调宗汤)on patients with coronary heart dis-ease angina pectoris.Methods A total of 102 patients with coronary heart disease angina pectoris admitted to The First Affiliated Hospital of Shihezi University School of Medicine from January 2020 to May 2022 were selected as the research objects.The pa-tients were randomly divided into observation group and control group.The control group was treated with standardized western medicine,and the observation group was treated with Xiaotiaozong Decoction on the basis of the control group.The clinical effica-cy,TCM symptom scores,electrocardiogram(ECG)efficacy and blood lipid level of the two groups were analyzed before and after treatment.Results The total effective rate of the observation group was 94.12%,higher than that of the control group(78.43%,P<0.05).After treatment,the scores of Traditional Chinese Medicine symptoms such as chest tightness,chest pain,spontaneous sweating,palpitations,shortness of breath,fatigue and insomnia in the observation group were lower than those in the control group(P<0.05).After treatment,the total effective rate of ECG in the observation group was 88.24%,higher than that in the control group(60.78%,P<0.05).After treatment,the levels of serum total cholesterol,triglyceride,low-density lipoprotein cholester-ol and high-density lipoprotein cholesterol in the observation group were better than those before treatment(P<0.05).After treatment,the improvement of each index level in the observation group was better than that in the control group(P<0.05).Conclusion Xiaotiaozong Decoction has a significant effect in the treatment of patients with stable coronary artery disease.It can improve the clinical symptoms,ECG ischemia and regulate blood lipid levels,and is worthy of clinical application.
Xiaodiaozong Decoction(小调宗汤)pectoral Qitraditional Chinese medicine symptom scorestable coronary artery diseaseclinical observation